R Mendoza

Surgical Care Practitioner/Urology ANP (Imperial College Healthcare NHS Trust) Robotic Surg🦾 + TP Prostate Bx 🎯

[Surgery and Cancer @ImperialSandC]

TRANSFORM study extends prostate cancer screening to Black men in the UK

S&C's @LondonProstate1 welcomes the news that all eligible Black men in the UK will be offered prostate cancer screening as part of the landmark TRANSFORM study ⬇️
https://t.co/5NucEQhzg1

[Imperial Prostate @IP_London]

Salvage focal therapy for radiorecurrent prostate cancer has comparable 10-year cancer-specific survival to radical prostatectomy, but fewer complications in matched analyses

Read our latest paper in @JAMAOnc!

https://t.co/WACzNt4sVk

By @AJWLight @LondonProstate1 @TaimurShah

[Surgery and Cancer @ImperialSandC]

A £1.89m clinical trial led by Professor Hash Ahmed (@LondonProstate1) is testing a novel scanning technology for high-risk prostate cancer, aiming to improve treatment planning and outcomes.
https://t.co/g62U7udiNK

🧵 4/6

[Imperial Prostate @IP_London]

Congratulations to Ms Mariana Bertoncelli Tanaka, appointed Consultant Urological Surgeon in Robotic Prostatectomy & Focal Therapy

👏 First female robotic prostatectomy surgeon in London & first female dual-accredited robotic + focal therapy surgeon in the UK!

@imperialurology

[Imperial Prostate @IP_London]

#TRANSFORM will be opening very soon! Our Trial Management Group met last week to discuss the final plans before recruitment begins.

[Imperial Prostate @IP_London]

#FocalTherapy “aims to spare men the incontinence, impotence and even penile shortening that have made treating #ProstateCancer one of the most controversial and polarizing fields in medicine.”

Read the interview with @LondonProstate1 in @BloombergUK: https://t.co/pDCrTILpP3

[Imperial NHS 💙 @ImperialNHS]

What's the best way to screen for and treat prostate cancer? Professor Hashim Ahmed (@LondonProstate1), chair of Urology at @ImperialNHS, talks to Bloomberg UK about the £42m TRANSFORM trial and much more. ➡️ https://t.co/cW85lM5ghZ

[Imperial Prostate @IP_London]

👏 A final robotic prostatectomy for our NIHR Clinical Lecturer @Connor_Urol under the mentorship of Mr Mathias Winkler and assisted by our amazing robotic theatre nursing team at Charing Cross Hospital.

Wishing him all the best at The Royal Marsden

[Imperial Prostate @IP_London]

And now Prof Ahmed @LondonProstate1 presents an update on the #TRANSFORM randomised prostate cancer screening study in the plenary session - recruitment starting later this year to answer some of the biggest questions in screening 📝📈 #EAU25

[Imperial Prostate @IP_London]

Building on this morning’s #NeuroSAFE data, @NikhilMayor presents late-breaking results from #IP8FLUORESCE, assessing the diagnostic accuracy of FCM for detecting positive margins intra-op

Feasible, quick and good sensitivity and specificity for detecting margins ≥3mm!

#EAU25

[Imperial Prostate @IP_London]

Is bpMRI non-inferior to mpMRI? Is image-fusion biopsy superior to cognitive biopsy?

@NikhilMayor gives an update on the #IP7PACIFIC trial with >1,000 patients recruited so far #EAU25 🇪🇸

[Prost8UK @prost8uk]

HIFU has been available on the NHS for 20 years, so why aren’t all men told about focal treatments?

Some consultants will only offer what they know like surgery or radiotherapy. It’s time for change. Help us raise awareness & fund HIFU equipment for NHS hospitals.

Donate in bio

[Imperial Prostate @IP_London]

🚨 We're launching the £1.89M #IP13AVIDITY trial to test PSMA PET/CT scans for detecting & escalating #ProstateCancer treatment funded by @ProstateUK

Co-led by @LondonProstate1 @Connor_Urol #TaraBarwick #RhianGabe #AdamBrentnall

@thetimes🗞️⤵️ https://t.co/ZbA2T4ksEB

[Times Radio @TimesRadio]

"There's a lot of uncertainty within the medical and research community."

Prostate cancer presents unique challenges to the NHS as there is no medical consensus on the best way to screen for the disease, says Professor Hashim Ahmed @LondonProstate1.

#TimesRadio | @AlexisConran

[Hashim U. Ahmed @LondonProstate1]

The balance of radical and focal that is right for our patients.

This balance is what all centres should be offering.

Sadly most men not even told about focal as an option. Advocates for screening should take note. No screening without focal therapy.

[R Mendoza @RLM_RN]

@KabirOlaAli Well deserved relaxation chief 👌🏽

[Prof. Prokar Dasgupta OBE HonFREng @prokarurol]

⁦@LoebStacy⁩ at #AAEU24 giving us a warning shot on misinformation on #prostatecancer on nearly 40% of #socialmedia posts!

Including using a dog dewormer causing serious liver problems!!

Doctors should empower their patients and have an educational role as advocates

[Imperial Prostate @IP_London]

The protocol paper for the IP8-FLUORESCE trial is now published #openaccess in @BJUIjournal! Excellent work led by @NikhilMayor and @SageOfLondon1

Keep tuned for the results!

Read for free: https://t.co/Ywrg9xZj1p

[Roland Pika @PikaRoland]

Delighted to have shared our tips on "how to be an efficient assistant in Robotic surgery" and promoting our training video at the Cardiothoracic robotic training day in the @RCSI_Irl
@mercaderclaudia
@LambAlastair
@tomleslie21
@uro_lopez
@Mutieraslan

[Imperial Prostate @IP_London]

🎉 A huge thank you to all the #IP5MATTER multicentre Trial Investigators across the UK for their hard work in recruiting over 300 patients from with newly-diagnosed metastatic prostate cancer (NCT04590976) published today in @EurUrolOncol @EUplatinum

🔗 https://t.co/BQJCsElya2